| Previous close | 2.0000 |
| Open | 2.9000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 290.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.0000 - 2.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksWaters (WAT) to Report Q1 Earnings: What's in the Offing?
Waters' (WAT) first-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.
ZacksEarnings Preview: Waters (WAT) Q1 Earnings Expected to Decline
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireWaters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.
© 2024 Yahoo. All rights reserved.